J Med Clin Nurs Stud, 2024 www.oaskpublishers.com Case Report Panic Disorder: Epidemiology, Etiology, and Treatment Strategies Dr. Eda Gorbis 1* and Aanya Jajoo 2 1 The Westwood Institute for Anxiety Disorders, Los Angeles, CA, United States 2 University of California, Los Angeles, CA, United States * Corresponding author Eda Gorbis, The Westwood Institute for Anxiety Disorders, 921 Westwood Blvd., Suite 223, Los Angeles, California 90024, United States. Received: August 28, 2024; Accepted: September 03, 2024; Published: September 07, 2024 Journal of Medical and Clinical Nursing Studies Page: 1 of 5 Citation: Eda Gorbis, Aanya Jajoo. Panic Disorder: Epidemiology, Etiology, and Treatment Strategies. J Med Clin Nurs Stud. 2024. 2(5): 1-5. DOI: doi.org/10.61440/JMCNS.2024.v2.59 ISSN: 3029-0872 ABSTRACT Panic disorder is a complex and debilitating anxiety disorder characterized by recurrent, unexpected panic attacks and associated anticipatory anxiety. This comprehensive review synthesizes current knowledge on the epidemiology, etiology, biology, and treatment of panic disorder. We discuss the prevalence, comorbidities, genetic factors, and neurobiological mechanisms underlying panic disorder, including detailed explorations of the noradrenergic and serotonergic systems. Additionally, we examine various treatment approaches, including pharmacological interventions (antidepressants and benzodiazepines) and cognitive-behavioral therapies, highlighting their efficacy, limitations, and long-term outcomes. This in-depth overview provides insights into the multifaceted nature of panic disorder, emphasizing the importance of a comprehensive approach to its management and suggesting directions for future research. Introduction Panic disorder is a significant mental health condition affecting approximately 2% of the general population. It is characterized by sudden, intense episodes of fear or discomfort, known as panic attacks, which are often accompanied by physical symptoms such as heart palpitations, shortness of breath, and dizziness. These attacks can lead to anticipatory anxiety and avoidance behaviors, potentially resulting in agoraphobia. The term “panic” originates from Pan, the ancient Greek god of woods and fields, who was believed to be responsible for the sudden, inexplicable fear experienced in lonely places. Modern understanding of panic disorder, however, recognizes it as a distinct clinical entity with its own etiology and treatment approaches. This review aims to provide a comprehensive overview of panic disorder, focusing on its epidemiology, etiology, biological underpinnings, and current treatment strategies. We hope to contribute to a better understanding of this complex disorder and inform future research and clinical practice. Epidemiology Prevalence and Demographics Panic disorder affects approximately 2% of the general population, with only about one-third of cases receiving treatment. The onset typically occurs in young adulthood, between the ages of 20 and 30, although it can also manifest in children. There is a decline in new cases after age 55. Women are twice as likely as men to develop panic disorder with agoraphobia. Panic disorder is associated with a history of separation anxiety and shyness in childhood. Kagan et al. at Harvard Infant Study Lab identified certain infants with colic, sleeplessness, and irritability who later exhibited behavioral inhibition and marked physiological arousal in novel situations during toddlerhood. This pattern, termed “behavioral inhibition to the unfamiliar,” is associated with a high rate of anxiety disorders by ages 6-9 [1-9]. Comorbidities Panic disorder frequently co-occurs with other psychiatric conditions. Major depression affects 56% of patients with panic disorder, while about 20% of patients with major depression have panic attacks (Noyes and Perry). Personality disorders are present in 30-60% of panic disorder patients, although many of these personality-related symptoms improve with successful treatment of panic disorder. Other common comorbidities include social phobia (30%), simple phobia (30%), and generalized anxiety disorder (GAD)